Managing Director and Chief Executive Officer
His experience encompasses leadership, marketing, operations and project management across diverse therapeutic areas, including oncology, haematology, cell therapies, fertility and cardiovascular disease. Craig has worked at VivaZome Therapeutics, CSL, Serono UK, Bio Nova International, AVAX Australia and Cryptome Pharmaceuticals, in roles such as Executive Director, Chief Operating Officer, Sales and Marketing Director and Business Unit Manager. Prior to his appointment as MD, and CEO, Craig was the Chief Operating Officer at Invion from April 2018 to October 2019. Craig has a Science degree and post-graduate qualifications in Management and in Marketing.
CFO and Company Secretary
Melanie's key experience includes project management of confidential and complex business activities, overall company reporting and compliance with regulatory authorities, restructures, IPOs, M&A and shareholder activities, along with corporate policy development for ASX-listed entities.
Melanie's previous roles include positions in the Office of HRH the Prince of Wales, Global Asset Management, Imperial Cancer Research Fund and The Prince's Foundation. Melanie holds a Bachelor of Communication (Public Relations), and a Graduate Diploma in Applied Corporate Governance. She is an Associate of the Governance Institute of Australia and an Associate of the Institute of Chartered Secretaries (UK).